Elevated level of plasma homocysteine in patients with slow coronary flow

Tambe, 1972, Angina pectoris and slow flow velocity of dye in coronary arteries. A new angiographic finding, Am. Heart J., 84, 66, 10.1016/0002-8703(72)90307-9 Mangieri, 1996, Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries, Catheter. Cardiovasc. Diagn., 37, 375, 10.1002/(SICI)1097-0304(199604)37:4<375::AID-CCD7>3.0.CO;2-8 Mosseri, 1986, Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries, Circulation, 74, 964, 10.1161/01.CIR.74.5.964 Christensen, 1991, Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of nontransformed, transformed, proliferating and quiescent cells in culture, J. Cell Biol., 146, 52 Selhub, 1993, Vitamin status and intake as primary determinants of homocysteinemia in an elderly population, JAMA, 270, 2693, 10.1001/jama.1993.03510220049033 Kang, 1993, Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease, Circulation, 88, 1463, 10.1161/01.CIR.88.4.1463 Graham, 1997, Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project, JAMA, 277, 1775, 10.1001/jama.1997.03540460039030 Boushey, 1995, A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes, JAMA, 274, 1049, 10.1001/jama.1995.03530130055028 Woo, 1997, Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans, Circulation, 96, 2542, 10.1161/01.CIR.96.8.2542 Tawakol, 1997, Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans, Circulation, 95, 1119, 10.1161/01.CIR.95.5.1119 Stamler, 1993, Adverse effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen, J. Clin. Invest., 91, 308, 10.1172/JCI116187 Gibson, 1996, TIMI frame count: a quantitative method of assessing coronary artery flow, Circulation, 93, 879, 10.1161/01.CIR.93.5.879 Dodge, 1988, Intrathoracic spatial location of specified coronary segments on the normal human heart: application in quantitative arteriography, assessment of regional risk and contraction, and anatomic display, Circulation, 78, 1167, 10.1161/01.CIR.78.5.1167 Epstein, 1985, Hemodynamic principles in the control of coronary blood flow, Am. J. Cardiol., 56, 4E, 10.1016/0002-9149(85)91169-5 Kurtoglu, 2001, Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow, Am. J. Cardiol., 87, 777, 10.1016/S0002-9149(00)01503-4 Beltrame, 2003, Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon, Am. Heart J., 146, 84, 10.1016/S0002-8703(03)00124-8 Camsari, 2003, Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow, Circ. J., 67, 1022, 10.1253/circj.67.1022 Cin, 2003, Diffuse intimal thickening of coronary arteries in slow coronary flow, Jpn. Heart J., 44, 907, 10.1536/jhj.44.907 Senen, 2004, Increased thrombolysis in myocardial infarction frame counts in patients with isolated coronary artery ectasia, Heart Vessels, 19, 23, 10.1007/s00380-003-0722-z Chambers, 1998, Acute hyperhomocysteinemia and endothelial dysfunction, Lancet, 351, 36, 10.1016/S0140-6736(05)78090-9 Constans, 1999, Endothelial dysfunction during acute methionine load in hyperhomocysteinemic patients, Atherosclerosis, 147, 411, 10.1016/S0021-9150(99)00260-9 Sezgin, 2003, Vascular endothelial function in patients with slow coronary flow, Coron. Artery Dis., 14, 155, 10.1097/00019501-200304000-00008 Starkebaum, 1986, Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine, J. Clin. Invest., 77, 1370, 10.1172/JCI112442 Welch, 1997, Hyperhomocysteinemia and atherothrombosis, Ann. N. Y. Acad. Sci. U. S. A., 811, 48, 10.1111/j.1749-6632.1997.tb51988.x Upchurch, 1995, The effect of homocysteine on endothelial cell nitric oxide production, FASEB J., 9, A876 Upchurch, 1995, Homocysteine attenuates endothelial glutathione peroxidase and thereby potentiates peroxide-mediated cell injury, Circulation, 92, I-228 Upchurch, 1997, Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase, J. Biol. Chem., 272, 17012, 10.1074/jbc.272.27.17012 Stanger, 2002, Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects, J. Pharmacol. Exp. Ther., 303, 158, 10.1124/jpet.102.036715 Willems, 2002, Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease, J. Am. Coll. Cardiol., 40, 766, 10.1016/S0735-1097(02)02016-8 Arnett, 1979, Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings, Ann. Intern. Med., 91, 350, 10.7326/0003-4819-91-3-350 Chemarin-Alibelli, 1996, Identification of coronary thrombus after myocardial infarction by intracoronary ultrasound compared with histology of tissues sampled by atherectomy, Am. J. Cardiol., 77, 344, 10.1016/S0002-9149(97)89361-7 Potkin, 1990, Coronary artery imaging with intravascular high-frequency ultrasound, Circulation, 81, 1575, 10.1161/01.CIR.81.5.1575